Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: New York NY, Mineola NY, East Brunswick NJ, Shirley NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07518186
Phase 3, Recruiting
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
for
Hepatitis
Location: New York NY, Newark NJ, The Bronx NY, Manhasset NY,
Sponsor: Bausch Health Americas, Inc.
Sex: All
Age: 18+
Code: NCT07428538
Phase 3, Recruiting
IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: New York NY, Hackensack NJ, Summit NJ, New Haven CT,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase 3, Recruiting
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for
Clostridoides Difficile Associated Disease
Location: New York NY, Brooklyn NY, Long Island City NY,
Sponsor: Pfizer
Sex: All
Age: 65+
Code: NCT07282665
Phase 3, Recruiting
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
for
Colorectal Cancer
Location: New York NY, New Brunswick NJ, New Haven CT,
Sponsor: Criterium, Inc.
Sex: All
Age: 18+
Code: NCT06992258
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors